Similar companies
Company | Transaction Value | |
---|---|---|
Abbott LaboratoriesABT |
-$4.8B | |
Tempus AITEM |
-$7.45B | |
TeleflexTFX |
-$40M | |
HCA HealthcareHCA |
-$256M | |
ProgynyPGNY |
-$1.08B |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Singer Maria Ruderman | Dec 11, 2024 | Sell | 1,614 | $191.1497 | $310,000 |
SUSSMAN ELLIOT J MD MBA | Aug 13, 2024 | Sell | 1,722 | $218.08 | $380,000 |
Nimetz Warren J. | Aug 12, 2024 | Sell | 3,444 | $217.64 | $750,000 |
Chen-Langenmayr Nina | Aug 7, 2024 | Sell | 850 | $212.11 | $180,000 |
McDonnell Eileen C. | Jul 26, 2024 | Sell | 2,535 | $209.5505 | $530,000 |
SUSSMAN ELLIOT J MD MBA | Jul 26, 2024 | Sell | 2,541 | $210.0023 | $530,000 |
Peterson Matthew Jay | Jul 26, 2024 | Sell | 7,814 | $210.4078 | $1.6M |
Peterson Matthew Jay | Jul 26, 2024 | Sell | 7,327 | $211.3186 | $1.5M |
Nimetz Warren J. | May 16, 2024 | Sell | 725 | $180.32 | $130,000 |
Singer Maria Ruderman | May 14, 2024 | Sell | 1,689 | $179.2938 | $300,000 |
FILTON STEVE | Mar 8, 2024 | Sell | 35,000 | $176.818 | $6.2M |
Peterson Matthew Jay | Mar 5, 2024 | Sell | 4,916 | $176.9 | $870,000 |
Peterson Matthew Jay | Mar 5, 2024 | Sell | 815 | $175.9 | $140,000 |
Peterson Matthew Jay | Mar 5, 2024 | Sell | 606 | $176.49 | $110,000 |
Peterson Matthew Jay | Mar 4, 2024 | Sell | 4,393 | $174.99 | $770,000 |
Peterson Matthew Jay | Mar 4, 2024 | Sell | 1,797 | $173.9 | $310,000 |
Peterson Matthew Jay | Mar 4, 2024 | Sell | 927 | $174.9 | $160,000 |
Peterson Matthew Jay | Mar 4, 2024 | Sell | 818 | $171.9 | $140,000 |
SUSSMAN ELLIOT J MD MBA | Mar 1, 2024 | Sell | 3,492 | $170.992 | $600,000 |
Chen-Langenmayr Nina | Dec 6, 2023 | Buy | 250 | $136.73 | $34,000 |
Chen-Langenmayr Nina | Dec 1, 2023 | Sell | 1,405 | $138.64 | $190,000 |
Nimetz Warren J. | Jun 13, 2023 | Sell | 800 | $140.9704 | $110,000 |
McDonnell Eileen C. | May 17, 2023 | Sell | 1,680 | $134.6365 | $230,000 |
FILTON STEVE | May 11, 2023 | Sell | 25,000 | $139.08 | $3.5M |
Nimetz Warren J. | May 11, 2023 | Sell | 500 | $139.014 | $70,000 |
Miller Marc D | May 10, 2023 | Sell | 24,282 | $142.109 | $3.5M |
Miller Marc D | May 10, 2023 | Sell | 17,460 | $143.2353 | $2.5M |
McDonnell Eileen C. | May 10, 2023 | Sell | 3,107 | $141.5332 | $440,000 |
Miller Marc D | May 10, 2023 | Sell | 2,368 | $143.8075 | $340,000 |
Gibbs Lawrence S. | Mar 7, 2023 | Sell | 793 | $122.31 | $97,000 |
Gibbs Lawrence S. | Mar 3, 2023 | Sell | 1,568 | $128.29 | $200,000 |
What's the latest insider transaction for Universal Health Services?
The most recent insider transaction for Universal Health Services was conducted by Singer Maria Ruderman, who sold 1,614 shares on December 11, 2024 at a price of $191.15 per share.
Which insider bought the most UHS stock over the last two years?
Chen-Langenmayr Nina has bought the most UHS stock in the last 2 years, with a total value of $34,000.
Which insider has sold the most UHS stock over the last two years?
FILTON STEVE has sold the most UHS stock in the last 2 years, with a total value of $9.7M.
What is the total value of insider transactions for Universal Health Services (UHS) in the last 2 years?
The total value of insider transactions for Universal Health Services in the last 2 years is negative, amounting to -$27M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Universal Health Services' market confidence?
Over the last 2 years, insider transactions for Universal Health Services have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.